Xenon Pharmaceuticals Inc (XENE)
Investing Cash Flow
-$637.29M
TTM · Period ending: · USD
XENE Investing Cash Flow
Latest reported-$637.29Mperiod ending
Latest reported-$637.29Mperiod ending
XENE TTM Cash from Investing (-$11.47M → -$637.29M)
TTM investing cash flow
High-resolution chart · PNG
XENE investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -637,292,000 | |
| -223,794,000 | |
| 217,998,000 | |
| 253,804,000 | |
| 215,771,000 | |
| 244,230,000 | |
| 166,527,000 | |
| -171,702,000 | |
| -124,168,000 | |
| -206,985,000 | |
| -117,170,000 | |
| 108,221,000 | |
| -173,908,000 | |
| -200,493,000 | |
| -296,003,000 | |
| -497,101,000 | |
| -247,429,000 | |
| -240,554,000 | |
| -246,770,000 | |
| 11,862,000 | |
| -23,167,401 | |
| -19,813,247 | |
| -17,634,247 | |
| -121,099,247 | |
| -93,895,846 | |
| -112,184,000 | |
| -66,291,000 | |
| -18,581,000 | |
| -49,678,000 | |
| -40,996,000 | |
| -28,987,000 | |
| -10,628,000 | |
| 12,631,000 | |
| 20,024,000 | |
| 24,294,000 | |
| -13,735,000 | |
| -13,757,000 | |
| -38,512,000 | |
| -47,842,000 | |
| -15,759,000 | |
| -6,939,000 | |
| 8,620,000 | |
| 10,194,000 | |
| 11,377,000 | |
| -2,741,000 | |
| -1,415,000 | |
| -3,244,000 | |
| -6,138,000 | |
| -10,279,000 | |
| -11,776,000 | |
| -11,472,000 | |
| -9,827,500 | |
| -487,000 |